These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8395669)

  • 1. Antitussive effects of mu- and kappa-agonists in diabetic rats.
    Kamei J; Iwamoto Y; Suzuki T; Misawa M; Nagase H; Kasuya Y
    Neurosci Lett; 1993 May; 154(1-2):65-8. PubMed ID: 8395669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of kappa-mediated antitussive activity in rats by a delta-agonist.
    Kamei J; Tanihara H; Kasuya Y
    Res Commun Chem Pathol Pharmacol; 1992 Jun; 76(3):375-8. PubMed ID: 1321982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitussive effects of naltrindole, a selective delta-opioid receptor antagonist, in mice and rats.
    Kamei J; Iwamoto Y; Suzuki T; Misawa M; Nagase H; Kasuya Y
    Eur J Pharmacol; 1993 Nov; 249(2):161-5. PubMed ID: 8287897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitussive effects of two specific kappa-opioid agonists, U-50,488H and U-62,066E, in rats.
    Kamei J; Tanihara H; Kasuya Y
    Eur J Pharmacol; 1990 Oct; 187(2):281-6. PubMed ID: 2272363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The kappa opioid agonist U-50,488H antagonizes respiratory effects of mu opioid receptor agonists in conscious rats.
    Dosaka-Akita K; Tortella FC; Holaday JW; Long JB
    J Pharmacol Exp Ther; 1993 Feb; 264(2):631-7. PubMed ID: 8382278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of mu-, delta- and kappa-opioid receptor subtypes in the discriminative-stimulus effects of delta-9-tetrahydrocannabinol (THC) in rats.
    Solinas M; Goldberg SR
    Psychopharmacology (Berl); 2005 Jun; 179(4):804-12. PubMed ID: 15619107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of opioidergic and serotonergic mechanisms in cough and antitussives.
    Kamei J
    Pulm Pharmacol; 1996; 9(5-6):349-56. PubMed ID: 9232674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The abilities of specific kappa-opioid agonists, U-50,488H and U-62,066E, to cause antitussive tolerance were lower than that of morphine.
    Kamei J; Tanihara H; Kasuya Y
    Jpn J Pharmacol; 1991 Aug; 56(4):557-61. PubMed ID: 1744997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioid control of the release of calcitonin gene-related peptide-like material from the rat spinal cord in vivo.
    Collin E; Frechilla D; Pohl M; Bourgoin S; Le Bars D; Hamon M; Cesselin F
    Brain Res; 1993 Apr; 609(1-2):211-22. PubMed ID: 8389648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Streptozotocin-induced diabetes selectively alters the potency of analgesia produced by mu-opioid agonists, but not by delta- and kappa-opioid agonists.
    Kamei J; Ohhashi Y; Aoki T; Kawasima N; Kasuya Y
    Brain Res; 1992 Feb; 571(2):199-203. PubMed ID: 1319265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitussive effect of dihydroetorphine in mice.
    Kamei J; Iwamoto Y; Suzuki T; Misawa M; Nagase H; Kasuya Y
    Eur J Pharmacol; 1994 Aug; 260(2-3):257-9. PubMed ID: 7988653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of differential modulation of mu-, delta- and kappa-opioid systems on bicuculline-induced convulsions in the mouse.
    Yajima Y; Narita M; Takahashi-Nakano Y; Misawa M; Nagase H; Mizoguchi H; Tseng LF; Suzuki T
    Brain Res; 2000 Apr; 862(1-2):120-6. PubMed ID: 10799676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different roles of mu-, delta- and kappa-opioid receptors in ethanol-associated place preference in rats exposed to conditioned fear stress.
    Matsuzawa S; Suzuki T; Misawa M; Nagase H
    Eur J Pharmacol; 1999 Feb; 368(1):9-16. PubMed ID: 10096764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of mu-opioid receptors in the antitussive effects of pentazocine.
    Kamei J; Katsuma K; Kasuya Y
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Feb; 345(2):203-8. PubMed ID: 1314961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of specific opioid agonists and antagonists to delineate the vagally mediated antinociceptive and cardiovascular effects of intravenous morphine.
    Randich A; Robertson JD; Willingham T
    Brain Res; 1993 Feb; 603(2):186-200. PubMed ID: 8096421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphine reduces the release of met-enkephalin-like material from the rat spinal cord in vivo by acting at delta opioid receptors.
    Collin E; Mauborgne A; Bourgoin S; Benoliel JJ; Hamon M; Cesselin F
    Neuropeptides; 1994 Jul; 27(1):75-83. PubMed ID: 7969822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naloxone-induced analgesia: involvement of kappa-opiate receptors.
    Bianchi M; Panerai AE
    Pharmacol Biochem Behav; 1993 Sep; 46(1):145-8. PubMed ID: 8255904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of kappa-opioid receptor mechanisms in the calcitonin-induced potentiation of opioid effects at the hypothalamus-pituitary-adrenocortical axis.
    Milanés MV; Vargas ML; Martín MI
    Eur J Pharmacol; 1994 Dec; 271(1):103-9. PubMed ID: 7698193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of mu-mediated antitussive activity in rats by a delta agonist.
    Kamei J; Tanihara H; Kasuya Y
    Eur J Pharmacol; 1991 Oct; 203(1):153-6. PubMed ID: 1665789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kappa opioid antagonist effects of the novel kappa antagonist 5'-guanidinonaltrindole (GNTI) in an assay of schedule-controlled behavior in rhesus monkeys.
    Negus SS; Mello NK; Linsenmayer DC; Jones RM; Portoghese PS
    Psychopharmacology (Berl); 2002 Oct; 163(3-4):412-9. PubMed ID: 12373442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.